that bacteria predominantly grow as sessile communities rather than as single cells. [1] [2] [3] 
48
Biofilms have traditionally been studied in simple models in the laboratory. Paul Stoodley and 49 colleagues presented a five-phase model of biofilm formation in vitro under continuous flow 50 conditions. 4 In the first stage planktonic cells reversibly attach to a surface. Irreversible binding 51 follows this attachment and then multiplication into microcolonies. These microcolonies produce 52 EPS, which in turn surrounds the colonies. After a couple of days the microcolonies attain tower-or 53 mushroom-like structures measuring up to 150m in the flow-cell.
2,4,5 The extracellular matrix 54 contains a mixture of polysaccharides, proteins and DNA. [6] [7] [8] When the biofilm grows to a size not 55 beneficial for bacterial survival and growth (e.g. due to nutrient limitations), focal areas of the 56 biofilm are liberated. It is hypothesized this enables the otherwise sessile biofilm bacteria to spread 57 and colonize to form a new biofilm. Hence it seems that the biofilm lifecycle is a dynamic process 58 capable of renewing itself.
2,4,5 59
However, it has been shown that biofilms in vitro ( Fig. 1 ) have little to do with biofilms found in 60 nature in terms of size and shape. 3, 9 It seems that biofilms causing harm in the human body are 61 rarely anchored to a solid surface but rather found in a semi-solid state in the tissue. Furthermore 62 the size of the infecting biofilms never reaches diameters larger than 100μm, unless the biofilm 63 habitats an undisturbed surface (e.g. catheter). 3, 9 64 65
The reason for the augmented interest in bacterial biofilms is their inherent tolerance towards 66 antimicrobial agents and inflammatory responses of the host. The ability to withstand antimicrobials 67 is divided into two subtypes. Traditionally antibiotic resistance has received most attention, however 68 it is antibiotic tolerance which is the prominent player of biofilm survival. Whereas resistance covers 69 the inherited features that directly impede the efficacy of the antimicrobial, tolerance is the ability 70 to sustain with the antibiotic due to the physical state of the bacterium. 71
Several resistance traits are found in the biofilm mode of growth and there are reports of increased 72 mutation rates in biofilms which enhance resistance development. [10] [11] [12] [13] The active export of 73 antimicrobials (including aztreonam, gentamicin, tetracycline and tobramycin) by efflux pumps, such 74 as the MexAB-OprM efflux pump, has been characterized in Pseudomonas aeruginosa biofilms and 75 other biofilm forming pathogens. [14] [15] [16] [17] [18] [19] By actively exporting the antimicrobial molecules lethal 76 concentrations are never reached within the bacterium and the bacterium will able to survive. 77
Another resistance trait found in biofilms is the production of antibiotic degrading enzymes such as 78 beta-lactamase. 13, 20, 21 The presence of beta-lactamase in a biofilm has been shown to change the 79 pharmacokinetics of β-lactam antibiotics from time-dependent killing to a dose-dependent and thus 80 further decreases the efficacy of the antibiotic. The biofilm matrix is composed of macromolecules including proteins, extracellular DNA and 87 polysaccharides. Although its composition is variable, the most prominent matrix molecule for P. 88 aeruginosa is probably the exopolysaccharide alginate, whereas exported cytoplasmic proteins 89 composed of N-acetylglucosamine are important in Staphylococcus aureus and glucans in 90 Streptococcus species. Evidence has shown that alginate and cyclic glucans in the periplasm of thebacteria may protect biofilms from aminoglycosides by binding the antibiotics. 25, 26 Also, another of 92 the major polysaccharides in the P. aeruginosa biofilm matrix (known as Psl), has been shown to 93 provide a physical barrier toward various antibiotics during the initial stages of biofilm 94 development. 27 It was found that Psl sequestered antibiotics (such as polymyxin B) to the matrix by 95 electrochemical interactions and thereby limited their access to the cell surface. 27 Another 96 important matrix molecule is extracellular DNA (eDNA). eDNA offers stability to the structure and 97 has been shown to enhance biofilm development. 7,28.29 Furthermore eDNA has been shown to bind 98 and decrease penetration of certain antibiotics (e.g. aminoglycosides) into biofilms. [30] [31] [32] 99 100
Additionally the growth rate and gene expression within a mature biofilm has been shown to 101 resemble a stationary phase culture and can thus explain the lack of efficacy by traditional 102 antibiotics, which is limited in such cultures.
9,33,34 The slow growth has been suggested to be a result 103 of reduced nutrient and oxygen availability caused by the matrix molecules. 35, 36 However, a study of 104
Alhede et al. showed that induction of growth, by disrupting the biofilm mechanically, left the 105 biofilm more sensitive to high concentrations of tobramycin when compared to the non-disrupted 106 biofilm. Interestingly, this was not the case when exposing the disrupted biofilm to colistin. 9 The 107 authors suggested that this difference could be explained by the fact that some of the antibiotic 108 resistance traits are metabolically taxing, e.g. the efflux pumps, thus that the low levels of nutrient 109 and oxygen within the biofilm couples the resistance properties with those of tolerance (i.e. the 110 slow growth). Pamp 
144
Irrefutable evidence of biofilms in wounds came from studies published in 2008. In one study 145 specific bacteria were located in sections of chronic wound tissue using peptide nucleic acid (PNA) 146 probes and fluorescent in situ microscopy (FISH). P. aeruginosa was detected in some instances as 147 single cells, but also as aggregates or microcolonies surrounded yet not invaded by host cells 53 . In 148 another study epifluorescent microscopy and scanning electron microscopy was utilised to visualise 149 large aggregates of bacteria in wound biopsies. Gram-positive cocci within an amorphous EPS were 150 most frequently observed, although some biofilms were composed of diverse species and this was 151 confirmed by molecular analysis. Whereas biofilm was only demonstrated in 1 of 16 acute wounds, it 152 was found in 30 of 50 chronic wounds. Hence biofilm was linked to wound chronicity (p> 0.001). 54 
153
Wounds are a well-suited habitat for bacteria, as the loss of skin integrity provides a moist and often 154 nutrient-rich setting. The microbiota of the deep dermal tissues of chronic wounds is well described 155 and harbours multiple bacterial species. [54] [55] [56] [57] The use of specific fluorescent probes and confocal laser 156 scanning microscopy (CLSM) has been used to detect biofilms in chronic venous leg ulcers, 58 The use of molecular techniques to characterise wound flora has revealed the presence of diverse 159 microbial species within chronic wounds. These mixed communities (Table 1 ) may indicate biofilms, 160 but do not actually provide information on the structural or physiological parameters of the 161 constituent member species that would indicate a biofilm phenotype. 162
Most studies agree on the almost universal presence of S. aureus, but another usual suspect found 163 in chronic wounds is P. aeruginosa, which is present in approximately half of the investigated 164 wounds. The organization and distribution of these two species has been elucidated by employing 165 specific PNA probes for FISH analysis. 58, 59 These observations revealed that the different bacterial 166 species might be present in the same wound but they do not integrate. Very few aggregates of 167 different bacteria in close proximity to each other were observed and never as part of a truly mixed 168 population. Based on available evidence it seems that bacteria in chronic infections aggregate mostly 169 as single species.
3, 58,59,65-67 This is in contrast to when bacteria aggregate in other natural 170 environments such as the floccs in wastewater treatment plants and the soil where several species 171 co-aggregate. This co-aggregation could be explained by the beneficial catabolism and anabolism of 172 compounds among the different bacteria. 68 The plausible reason why multispecies biofilms are not 173 common in chronic infections is that the nutrient availability is high and that symbiosis between 174 different species is not a crucial requisite for growth. The key challenge for colonizing bacteria is 175 rather whether they can survive the encounter with the defence system. 176
Impact of biofilms in wounds 177
Based on the evidence above, the concept of bacterial biofilms in chronic wounds is supported, but 178 whether these biofilms play a role in the lack of healing is another question. The biofilm phenotype 179 enables protection of the bacteria from both antibiotics and other antimicrobial agents such as silver 180 and the host defence. This implies that if the bacteria succeed in forming a biofilm in the wound bed, 181 the bacteria will be extremely difficult to eradicate. Data suggest that the presence of certain 182 bacteria (e.g. P. aeruginosa) can induce ulcer enlargement, delay healing 66 and failure of split skin 183 transplantation.
69 It has also suggested that bacteria (i.e. P. aeruginosa) located in the deeper 184 regions of the wounds might play a role in keeping the wounds arrested in a stage dominated by 185 inflammatory processes. 70 Evidence that biofilm contributes to chronic inflammation in a wound 186
exists, but how that influences wound healing is unclear. We know that biofilms are not the cause of 187 chronic wounds, but they might keep the wound from healing. identification of bacteria. 58 The classic culturing methods revealed S. aureus to be present in the 205 majority of the wounds, whereas P. aeruginosa was cultured less frequently. In contrast, using PNA 206 FISH, P. aeruginosa was visualized in biofilms in almost half of the wounds. These P. aeruginosa 207 biofilms were detected inside the wound bed, whereas S. aureus, when present, was detected on 208 the surface of the wounds. Thus, it seems that, although being the gold standard, culturing is not 209 successful for diagnosing biofilms of P. aeruginosa in wounds due to its deep localization. This is 210 supported by the observations by other observers demonstrating S. aureus in microcolonies on the 211 surface of the wound bed. 59, 71 It was shown that the distance of the P. aeruginosa biofilm to the 212 wound surface was significantly greater than that of the S. aureus biofilms, suggesting that the 213 distribution of the bacteria in the chronic wounds was non-random. 59 
214
As described above, the microbiota in chronic wounds has been investigated for several years. In 215 one study Gjødsbol et al investigated the microbiota by standard culturing. 57 Several different 216 bacterial species were found in chronic venous leg ulcers, such as S. aureus (in 93.5% of the 217 investigated ulcers), Enterococcus faecalis (71.7%), P. aeruginosa (52.2%), coagulase-negative 218 staphylococci (45.7%), Proteus species (41.3%), and anaerobic bacteria (39.1%). Another study also 219 investigated the flora in chronic wounds by culturing and found the most common bacteria to beStaphylococcus (65%), Enterococcus (62%), Pseudomonas (35%) ( Table 1 ). Molecular techniques 221 have also been used to establish the microbiota and in several studies it has been shown that 222 standard culturing of bacteria from wound samples does not reveal on the true bacterial diversity in 223 the wounds.
56,58, As mentioned above, the localization, the presence and slow growth of biofilms 224 makes culturing difficult. Additionally a large population of anaerobic bacteria in wounds has been 225 identified, 56 and these bacteria are also difficult to culture. 226
By using molecular techniques, even small populations of a specific bacterium can be detected. The 227 drawback is that these techniques are qualitative which means that they do not reveal the relative 228
proportions between the different bacteria or how they are organized and distributed in the 229 wounds, as microscopy can do. Another just as important drawback is that these techniques cannot 230 be used to identify which bacteria play a key role in the impairment of the wound healing process. 231
Most importantly the bacteria in chronic wounds are very small and heterogeneously distributed.
55,70 232
This means that sampling from a chronic wound, especially using biopsies, might show false negative 233
results. 234
In summary swabs from chronic wounds are not representative for the microbiota and biopsies 235 might give false negative results. Therefore it is suggested to combine a thorough swab covering the 236 whole wound surface with several biopsies, which should be investigated by both molecular 237 techniques and culturing (aerobically and anaerobically). 
Interference with attachment 248
Lactoferrin is part of the human innate immune response; it is found in tears, saliva, mucous and 249 milk. It binds to components in the cell walls of Gram-negative bacteria to cause destabilisation, 250 leakiness and ultimately bacterial lysis. It also binds avidly to iron, which is needed for bacterial 251 motility during the initial stages of adherence to surfaces. 74 Xylitol is an artificial sweetener that 252 binds to the cell surface of Gram-positive bacteria that blocks adherence. 81 QS systems allow bacteria to "sense" bacterial 264 density in the environment and respond by changes in gene expression. 82 By specifically targeting 265 the QS system the idea is not to kill or detach the biofilm directly but to render the biofilm more 266 susceptible to antibiotics and prevent expression of harmful virulence factors. 267
The first compounds showing good inhibition of the QS system were the synthetic furanones C-30 268 and C-56. 83, 84 In vitro P. aeruginosa biofilms were significantly less tolerant to 100 μg /ml tobramycin 269 when treated with furanone C-30. 83 In addition, in vivo studies in a pulmonary mouse model 270 confirmed the potential of the furanones by demonstrating that bacteria were cleared faster in 271 furanone-treated versus untreated mice. 83, 86 Two QSIs from natural sources have recently been 272 isolated: iberin from horseradish and ajoene from garlic. interfere with quorum sensing in Gram-negative bacteria.
87-89 Manuka honey has also been shown to 275 down-regulate three of the four genes essential for functional quorum sensing in MRSA, with knock-276 on effects on virulence and biofilm genes. 90 
277

Biofilm disruption 278
The use of sharp debridement is one way to reduce biofilm within a wound, but it rarely offers a 279 permanent solution because, as with dental plaque, any remaining cells are able to regenerate the 280 biofilm. Degradation of biofilm matrix with either cocktails of enzymes (e.g. DNAse) or maggot 281 secretions has been reported. 91, 92 Generation of hydrogen peroxide by enzymes within an alginogel 282 disrupt biofilms in vitro 93 and several honeys can also disrupt biofilms.
94-97
Ultrasound as antibiofilm treatment 284
A lot of research has thus been invested in finding non-invasive applications to overcome the 285 problem of antibiotic resistance and tolerance. Promising studies show that exposing bacteria to 286 ultrasound enhances the antibiotic efficacy. However, the underlying mechanisms of this effect are 287 yet to be elucidated. Additionally, recent studies suggest that any mechanical force (e.g. ultrasound 288 or shear) can be applied to re-sensitize biofilm bacteria by tearing the biofilm and stripping off the 289 sessile cells.
9 Back in the planktonic state, the bacteria lose the tolerance provided by the biofilm. 290
Such disruption of the biofilm by ultrasound is denoted destructive ultrasound. 291 292 Studies show that exposing P. aeruginosa simultaneously to low intensity ultrasound and 293 aminoglycosides (e.g. tobramycin) improves the antibiotic efficacy.
98-105 The authors found that 294 ultrasound alone did not affect the cell viability and that the synergistic effect was only observed if 295 the antibiotics were applied during the ultrasonic exposure. However in another study, Qian et al. 296
could not detect any structural difference in the biofilm by CLSM during ultrasonic exposure, 106 and 297 further documented that the effect was also evident on planktonic P. aeruginosa as well. , and Nikaido, 109 who documented that low intensity ultrasound increased the 300 permeability of P. aeruginosa to several tagged molecules. This ultrasonically induced permeability 301 displayed the same frequency and peak pressure dependence as the above experiments. In addition, 302 studies by Pong et al showed a similarly increased permeability of phospholipid vesicles. 110 Runyan 303 et al. concluded that the effect was due to increased penetration of the antibiotics through the cell 304 membrane of P. aeruginosa. 108 
306
In addition to the resulting transient permeability, much attention has been addressed to the 307 destructive ultrasound in order to remove biofilms from implants and wounds. 106, [111] [112] [113] By showing 308 that disruption of biofilms by mechanical force yields an enhanced effect of applied antibiotics, it 309 was proven that biofilm tolerance is reversible. 9 This had been hypothesised to be due to disruption 310 of matrix molecules and induction of growth by exposing the cells to nutrients. This inference was 311 supported by the findings of Pitt et al. 114 
312
From published studies it seems that the mode of action by ultrasound has given rise to confusion 313 and that both the terms "destructive" and "bioacoustic effect" have been used inconsistently. 314
However, given that the above hypotheses are valid, both destructive ultrasound and the 315 bioacoustic effect enhance the antibiotic efficacy, albeit in entirely different ways: one acting on the 316 biofilm, the other directly on the individual bacterium. 317
Ultrasound debridement of wounds 319
Treatment of chronic wounds with ultrasound therapy has been used with seemingly good 320 results. 115, 116 It has been suggested that the positive effect comes from a multitude of factors such as 321 cellular recruitment and stimulation, collagen synthesis, angiogenesis, fibrinolysis. 117, 118 Recently the 322 knowledge of biofilms in non-healing wound has led to the hypothesis that the ultrasound, in 323 addition to the above mentioned parameters, aids biofilm disruption and thereby wound healing. 119 
324
Measuring wound healing and quantifying the presence of biofilms/bacteria is extremely difficult (if 325 not impossible) and therefore the literature is very limited in this perspective. Escandon and 326 colleagues found a non-significant decline in individual and total bacterial counts when treating 327 refractory venous leg ulcers with non-contact ultrasound therapy. 116 It should be noted that biofilms 328 able to prevent wound healing are smaller than 100μm in diameter and often situated deep in the 329 wound bed and thereby hard to find by traditional means. The safety of such an approach has been tested in a phase I trial conducted on venous leg ulcers in 359
America. Here 42 patients were treated for 12 weeks with either saline control or a cocktail of 360 phages directed at P. aeruginosa, S. aureus and E. coli. Neither adverse events nor significant 361 differences between the two study groups were observed. At present the number of clinical studies in which eradication of biofilms has been investigated is 373 limited and will probably remain so until a routine test to detect biofilm in wound tissue is 374 developed. A concept of biofilm-based wound care (BBWC) has been proposed in which sharp 375 debridement to reduce biofilm is followed by antimicrobial agents to limit biofilm reformation. The 376 rationale for this approach is based on physically removing biofilm and inhibiting the residual 377 bacteria that actively try to reform biofilm before they return to their tolerant status. In a 378 retrospective study BBWC of 190 patients with critical limb ischaemia were treated by sharp 379 debridement coupled with ultrasound, followed by lactoferrin and xylitol, silver, cadexomer iodine 380 and antibiotics. Improved healing was observed in these patients compared to a previous study, but 381 the presence of biofilms before and after treatment was not confirmed by electron or confocal 382 scanning laser microscopy. with only a limited matrix shield and therefore are highly susceptible to most antimicrobials. Biofilms 395 across species and models seems to become tolerant between 20 hours and 48 hours after 396 inoculation but continue developing this tolerance with time.
3,9 Another important limitation of in 397 vitro models is that they have been developed under artificial conditions that aim to simulate the 398 natural situations in which biofilms are normally established, and because the validity of these 399 models is questionable, data obtained is not necessarily transferable to clinical practice. 400
Future prospects 401
Discovering biofilms in wounds has given insight into some of the reasons why wounds fail to heal. It 402 has helped to explain the limited efficacy of antibiotics in chronic wounds and it has stimulated 403 research into innovative anti-biofilm strategies. However, we still face a number of tasks to solve 404 before chronic wounds are history. The range of possible treatment strategies of biofilm infections 405 needs to be expanded and the in vitro models need to be more closely aligned to simulate the 406 wound in vivo. P. aeruginosa is the test organism that is commonly used in laboratory biofilm models 407 because it is easy to grow, its genome has been sequenced and knock out mutants are available. 408
Testing a broader range of wound microbiota in both single species and mixed species models might 409 provide a different perspective. Most importantly, in order to prove that biofilm plays the role it is 410 believed to do, we need to improve diagnostic methods to eliminate false negatives. This task is 411 especially important when evaluating treatment strategies in the clinic. 
